Literature DB >> 15206636

Psychotropic medications prescribing patterns for children and adolescents in New York's public mental health system.

John S Lyons1, James C MacIntyre, Michael E Lee, Sharon Carpinello, Michael P Zuber, Marcia L Fazio.   

Abstract

CONTEXT: Breakthroughs in the development of effective medications for a number of psychiatric disorders have led to increased use of these compounds in the treatment of children.
OBJECTIVES: To understand the use of psychotropic medications in the treatment of children, a state-wide study was undertaken based on the data collected in a large planning study. DATA AND
SETTING: A stratified random sample of 10 different program types in New York State produced data on children served in different specialty mental health services. PARTICIPANTS: Randomly selected cases were reviewed at a randomly selected sites to generate a sample of 1592 cases on which data were collected on clinical presentation and service use, including psychotropic medication prescriptions. MAIN OUTCOME MEASURES: The Child and Adolescent Needs and Strengths (CANS-MH) tool was used to provide a reliable review of clinical indicators.
RESULTS: Psychotropic medication use is common in the children's public mental health service system in New York. Most children served in high intensity settings receive medication as a part of their treatment. It appears that most prescriptions for stimulants and antidepressants are consistent with either diagnostic or symptom indications. Many children with these indications are not on medications. On the other hand, a large number of children without evidence of psychosis receive antipsychotic medications.
CONCLUSION: The evidence suggests that stimulant and antidepressant are not over-prescribed. However, the use of antipsychotic medications for other indications is a priority for further research.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15206636     DOI: 10.1023/b:comh.0000022731.65054.3e

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  20 in total

Review 1.  Antipsychotic medications for children and adolescents.

Authors:  B L Gracious; R L Findling
Journal:  Pediatr Ann       Date:  2001-03       Impact factor: 1.132

2.  Psychotropic practice patterns for youth: a 10-year perspective.

Authors:  Julie Magno Zito; Daniel J Safer; Susan DosReis; James F Gardner; Laurence Magder; Karen Soeken; Myde Boles; Frances Lynch; Mark A Riddle
Journal:  Arch Pediatr Adolesc Med       Date:  2003-01

3.  Regional variation and clinical indicators of antipsychotic use in residential treatment: a four-state comparison.

Authors:  Purva H Rawal; John S Lyons; James C MacIntyre; John C Hunter
Journal:  J Behav Health Serv Res       Date:  2004 Apr-Jun       Impact factor: 1.505

Review 4.  Effective treatment for mental disorders in children and adolescents.

Authors:  B J Burns; K Hoagwood; P J Mrazek
Journal:  Clin Child Fam Psychol Rev       Date:  1999-12

Review 5.  National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD)

Authors: 
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-02       Impact factor: 8.829

6.  Medication management of stimulants in pediatric practice settings: a national perspective.

Authors:  K Hoagwood; P S Jensen; M Feil; B Vitiello; V S Bhatara
Journal:  J Dev Behav Pediatr       Date:  2000-10       Impact factor: 2.225

7.  "Real world" atypical antipsychotic prescribing practices in public child and adolescent inpatient settings.

Authors:  Elizabeth Pappadopulos; Peter S Jensen; Sarah B Schur; James C MacIntyre; Scott Ketner; Kimberly Van Orden; Jeffrey Sverd; Sadhana Sardana; David Woodlock; Robert Schweitzer; David Rube
Journal:  Schizophr Bull       Date:  2002       Impact factor: 9.306

8.  Trends in the prescribing of psychotropic medications to preschoolers.

Authors:  J M Zito; D J Safer; S dosReis; J F Gardner; M Boles; F Lynch
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

Review 9.  Developmental perspectives in pediatric psychopharmacology.

Authors:  B Vitiello; P S Jensen
Journal:  Psychopharmacol Bull       Date:  1995

Review 10.  Psychopharmacology of children and adolescents: pharmacokinetics and relationships of plasma/serum levels to response.

Authors:  B Geller
Journal:  Psychopharmacol Bull       Date:  1991
View more
  6 in total

Review 1.  Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research.

Authors:  Nasra Haroun; Laura Dunn; Ansar Haroun; Kristin S Cadenhead
Journal:  Schizophr Bull       Date:  2005-10-05       Impact factor: 9.306

Review 2.  Drug utilization review across jurisdictions--a reality or still a distant dream?

Authors:  Lisa K Pulver; Susan E Tett
Journal:  Eur J Clin Pharmacol       Date:  2006-01-10       Impact factor: 2.953

3.  The premature demise of public child and adolescent inpatient psychiatric beds : Part II: challenges and implications.

Authors:  Jeffrey L Geller; Kathleen Biebel
Journal:  Psychiatr Q       Date:  2006

Review 4.  Overuse of antidepressant drugs for the treatment of depression.

Authors:  Jon Jureidini; Anne Tonkin
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Facts, values, and attention-deficit hyperactivity disorder (ADHD): an update on the controversies.

Authors:  Erik Parens; Josephine Johnston
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2009-01-19       Impact factor: 3.033

6.  Parental attitudes and opinions on the use of psychotropic medication in mental disorders of childhood.

Authors:  Helen Lazaratou; Dimitris C Anagnostopoulos; Elias V Alevizos; Fotini Haviara; Dimitris N Ploumpidis
Journal:  Ann Gen Psychiatry       Date:  2007-11-15       Impact factor: 3.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.